Experimental

Site-directed mutagenesis
FamC1 variants were prepared by using QuickChange site-directed mutagenesis kit (Agilent Technologies, Santa Clara, CA, USA) following the manufacturer's instructions. pET28a-famC1 plasmid constructed as described previously 1 N137A/E175A double mutant was constructed by introducing E175A mutant to the N137A singlet. Similarly, E39A/N95A/E98A/D216A was constructed by introducing individual mutation to the single, double, and eventually triple mutants. The recombinant plasmids were verified by sequencing.
Expression and purification of recombinant FamC1 variants
The plasmids carrying FamC1 variants were transformed into E. coli BL21(DE3) 
Enzyme activity measurement
The enzymatic activity of wild type and mutant FamC1 was measured in a one-pot reaction which comprises two-enzyme reaction system as described previously. 1
Briefly, 100 l reaction containing 1 mM cis-indole isonitrile, 1 mM GPP, 5 M 
Crystallization, data collection, structure determination and refinement
Sitting-drop vapor diffusion method was used for crystallization of FamC1 variants. In general, 1 µL protein (10 mg/mL) was mixed with 1 µL of reservoir solution in 48-well Cryschem Plates, and equilibrated against 100 µL of the reservoir at 25 °C. (NSRRC, Hsinchu, Taiwan) and processed by using HKL2000. 2 Prior to structure refinement, 5 % randomly selected reflections were set aside for calculating R free 3 as a monitor of model quality. The phase information of the structures of FamC1 N137A
was solved by using molecular replacement program Phaser 4 in CCP4i suit 5 using crystal structure of apo form FamC1 (PDB ID, 5YVK). All structural refinements were carried out using Phenix 6 and Coot. 7 All figures were prepared by using the PyMOL program (http://pymol.sourceforge.net/). Values in parentheses are for the highest resolution shell.
